The NHS will now pay for the Libre 3 system as part of its NHS Supply Chain Network.
Abbott ’s FreeStyle Libre 3 continuous glucose monitoring system is now available to eligible patients in the UK thanks to its listing on the NHS Supply Chain Network, the company announced 15 March.
The Libre 3, which is approved for up to 14 days of continuous monitoring, is roughly the size of a £1 coin (two stacked US pennies), making it 70% smaller...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
